- Home
- BY vs WVE Comparison
BY vs WVE Comparison
Compare BY & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BY
- WVE
- Stock Information
- Founded
- BY 1914
- WVE 2012
- Country
- BY United States
- WVE Singapore
- Employees
- BY N/A
- WVE N/A
- Industry
- BY Major Banks
- WVE Biotechnology: Pharmaceutical Preparations
- Sector
- BY Finance
- WVE Health Care
- Exchange
- BY Nasdaq
- WVE Nasdaq
- Market Cap
- BY 1.1B
- WVE 984.9M
- IPO Year
- BY 2017
- WVE 2015
- Fundamental
- Price
- BY $25.84
- WVE $6.17
- Analyst Decision
- BY Hold
- WVE Strong Buy
- Analyst Count
- BY 3
- WVE 11
- Target Price
- BY $33.67
- WVE $20.91
- AVG Volume (30 Days)
- BY 133.8K
- WVE 1.5M
- Earning Date
- BY 07-24-2025
- WVE 05-08-2025
- Dividend Yield
- BY 1.55%
- WVE N/A
- EPS Growth
- BY N/A
- WVE N/A
- EPS
- BY 2.69
- WVE N/A
- Revenue
- BY $379,386,000.00
- WVE $104,939,000.00
- Revenue This Year
- BY $16.23
- WVE N/A
- Revenue Next Year
- BY $3.79
- WVE N/A
- P/E Ratio
- BY $9.62
- WVE N/A
- Revenue Growth
- BY 3.48
- WVE N/A
- 52 Week Low
- BY $21.96
- WVE $4.25
- 52 Week High
- BY $32.89
- WVE $16.74
- Technical
- Relative Strength Index (RSI)
- BY 43.73
- WVE 39.86
- Support Level
- BY $25.57
- WVE $5.98
- Resistance Level
- BY $27.30
- WVE $6.30
- Average True Range (ATR)
- BY 0.35
- WVE 0.31
- MACD
- BY -0.15
- WVE 0.01
- Stochastic Oscillator
- BY 7.51
- WVE 15.79
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.